Nonhormonal selective estrogen receptor modulator 1-(2-[4-{(3R,4S)-7-Methoxy-2, 2-dimethyl-3-phenyl-chroman-4yl}phenoxy]ethyl)pyrrolidine hydrochloride (ormeloxifene hydrochloride) for the treatment of breast cancer-Reference-Cited by-同舟云学术

Nonhormonal selective estrogen receptor modulator 1-(2-[4-{(3R,4S)-7-Methoxy-2, 2-dimethyl-3-phenyl-chroman-4yl}phenoxy]ethyl)pyrrolidine hydrochloride (ormeloxifene hydrochloride) for the treatment of breast cancer

Published:2018-09 Issue:6 Volume:79 Page:275-286
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev Res

Author:

Pillai Lakshmi Sreedharan¹,Regidi Saikant¹,Varghese Shiny Deena¹,Ravindran Shilpa¹,Maya Vani¹,Varghese Jesline¹,Ramaswami Kartik¹,Gopimohan Rajmohan¹,Gopi Manoj¹^ORCID

Affiliation:

1. Cell Culture & Clinical Research Facility, Corporate R&D Centre; HLL Lifecare Limited; Trivandrum India

Funder

HLL Lifecare Limited

WOS-A Scheme, Department of Science and Technology, Government of India

Publisher

Wiley

Subject

Drug Discovery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ddr.21440/fullpdf

Reference52 articles.

1. PEGylated chitosan nanoparticles potentiate repurposing of ormeloxifene in breast cancer therapy;Agrawal;Nanomedicine,2016

2. Ormeloxifene-induced unfolded protein response contributes to autophagy-associated apoptosis via disruption of Akt/mTOR and activation of JNK;Arindam;Scientific Reports,2018

3. Role of poly (ADP-ribose) polymerase (PARP) cleavage in apoptosis Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells;Boulares;The Journal of Biological Chemistry,1999

4. Tamoxifen and risk of idiopathic venous thromboembolism;Christoph;British Journal of Clinical Pharmacology,1998

5. Early breast cancer Trialists collaborative group (EBCTCG), relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials;Davies;Lancet,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Folic acid-tripeptide-conjugated synthetic biodegradable nanoparticle-loaded with Ormeloxifene potentially inhibited breast cancer xenograft tumor;Journal of Drug Delivery Science and Technology;2024-08

2. Evaluation of molecular effects associated with apoptosis, tumour progression, angiogenesis and metastasis by a novel combination of drugs with ormeloxifene in triple negative breast cancer cells;Exploration of Targeted Anti-tumor Therapy;2024-06-11

3. Effect of drug encapsulation and sterilization process on physicochemical properties and release of combined steroid hormones from poly (ε-caprolactone) fibers;Journal of Drug Delivery Science and Technology;2024-02

4. Anticancer properties of arylchromenes and arylchromans: an overview;Physical Sciences Reviews;2022-02-02

5. Comparative differential cytotoxicity of clinically used SERMs in human cancer lines of different origin and its predictive molecular docking studies of key target genes involved in cancer progression and treatment responses;Current Research in Pharmacology and Drug Discovery;2022